首页 » 细胞株Cell Lines 100及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 100及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV100
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

http://www.biovector.net


ID   TA-85B5

AC   CVCL_2212

DR   DSMZ; ACC-624

CC   Doubling time: ~60-70 hours (DSMZ).

CC   Breed/subspecies: Wistar-AF/Han.

DI   NCIt; C60682; Rat digestive system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Ta288

AC   CVCL_6D38

SY   T.a 288

RX   PubMed=1979317;

CC   Characteristics: Infected by Theileria annulaza isolate Ankara.

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   TA3

AC   CVCL_4315

DR   ChEMBL-Cells; CHEMBL3307258

DR   ChEMBL-Targets; CHEMBL613285

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-145.html

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   TA3/Ha

AC   CVCL_4321

SY   TA3-Ha; TA3 Hauschka

DR   CLO; CLO_0009262

DR   CLDB; cl4484

DR   ECACC; 85061102

RX   PubMed=460789;

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4315 ! TA3

SX   Female

CA   Cancer cell line

//

ID   TA3/St

AC   CVCL_4316

SY   TA3-St; TA3 Stockholm

DR   TOKU-E; 4019

RX   PubMed=460789;

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4315 ! TA3

SX   Female

CA   Cancer cell line

//

ID   Ta363

AC   CVCL_6D39

RX   PubMed=1979317;

CC   Characteristics: Infected by Theileria annulaza isolate Ankara.

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   TAB089

AC   CVCL_E842

SY   TAB

DR   dbMHC; 49034

DR   ECACC; 88052066

DR   IHW; IHW9066

DR   IMGT/HLA; 11424

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl66.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   TAB1

AC   CVCL_GZ67

RX   PubMed=12579318;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TAC-1

AC   CVCL_3468

DR   CLO; CLO_0009263

DR   ATCC; CRL-10632

RX   Patent=US5093259;

CC   Group: Non-human primate cell line.

CC   Discontinued: ATCC; CRL-10632; probable.

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Male

CA   Cancer cell line

//

ID   TAC-2

AC   CVCL_G954

SY   TAC2; TubuloAlveolar Colony-2

RX   PubMed=7768990;

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0075 ! NMuMG

CA   Finite cell line

//

ID   TaC12

AC   CVCL_2G84

SY   TaC 12

CC   Characteristics: Infected by Theileria annulata.

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   TaD-1

AC   CVCL_5635

SY   TaD1

DR   IFO; IFO50112

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   TaD-1-2

AC   CVCL_M863

SY   TaD1-2

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-3

AC   CVCL_5636

SY   TaD1-3

DR   IFO; IFO50120

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-4

AC   CVCL_M864

SY   TaD1-4

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-5

AC   CVCL_M865

SY   TaD1-5

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-6

AC   CVCL_M866

SY   TaD1-6

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-7

AC   CVCL_M867

SY   TaD1-7

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TaD-1-8

AC   CVCL_5637

SY   TaD1-8

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM x Buffalo/Mna.

DI   NCIt; C60470; Rat malignant thymoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5635 ! TaD-1

SX   Male

CA   Cancer cell line

//

ID   TAD-2

AC   CVCL_5370

SY   TAD2

DR   BTO; BTO:0004770

DR   ATCC; CRL-2855

DR   BioSample; SAMN03471804

RX   PubMed=1973649;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-2855; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,7

ST   TPOX: 7,8

ST   vWA: 13,16

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   Tahr87

AC   CVCL_A398

SY   TAHR-87; Tahr-87; Tahr 87

DR   Cosmic; 999767

DR   Cosmic; 1281354

DR   Cosmic; 2491092

RX   PubMed=7688832;

RX   PubMed=9067587;

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TAI034

AC   CVCL_E843

SY   TAI 034

DR   dbMHC; 49035

DR   ECACC; 94082210

DR   IHW; IHW9111

DR   IMGT/HLA; 11656

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl111.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   TAK3

AC   CVCL_2729

DR   CLO; CLO_0009264

DR   CLDB; cl4485

DR   ECACC; 93093004

RX   PubMed=6438434;

RX   PubMed=6817143;

WW   http://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   TAKA-1

AC   CVCL_T061

RX   PubMed=8581919;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Takigawa

AC   CVCL_3176

DR   BioSample; SAMN03473263

DR   CGH-DB; 137-1

DR   Cosmic; 1122340

DR   Cosmic; 1187296

DR   GDSC; 1299066

DR   JCRB; JCRB0124

DR   JCRB; NIHS0182

CC   Discontinued: JCRB; NIHS0182; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 14

ST   D18S51: 22

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 12

ST   D8S1179: 10,13

ST   FGA: 22

ST   Penta D: 12

ST   Penta E: 23

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Tal Jo

AC   CVCL_3469

DR   CLO; CLO_0009265

DR   ATCC; CRL-1267

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   TALH SVE.1

AC   CVCL_4317

AS   CVCL_U960

SY   TALH-SVE.1; TALH,SVE.1; TALH; Thick Ascending Limb of Henle's loop

DR   BTO; BTO:0004609

RX   PubMed=1504097;

RX   PubMed=1847303;

RX   PubMed=2427348;

RX   PubMed=9312212;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA   Transformed cell line

//

ID   TALL-1

AC   CVCL_1736

SY   TALL1; T-ALL-1; T-ALL1

DR   BTO; BTO:0003739

DR   CLO; CLO_0051547

DR   BioSample; SAMN03472057

DR   BioSample; SAMN03473519

DR   CCLE; TALL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308541

DR   ChEMBL-Targets; CHEMBL2366254

DR   Cosmic; 909762

DR   Cosmic; 1375581

DR   Cosmic; 1641379

DR   Cosmic; 1760534

DR   Cosmic; 1760556

DR   Cosmic; 2165721

DR   Cosmic-CLP; 909762

DR   DSMZ; ACC-521

DR   GDSC; 909762

DR   GEO; GSM887688

DR   GEO; GSM888780

DR   JCRB; JCRB0086

DR   RCB; RCB2084

DR   TKG; TKG 0251

RX   PubMed=3496132;

RX   PubMed=6966589;

RX   PubMed=9290701;

RX   PubMed=10071127;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=22675565;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~50-70 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG

ST   Amelogenin: X,Y (Cosmic-CLP; DSMZ; JCRB)

ST   Amelogenin: X (RCB; TKG)

ST   CSF1PO: 11,13

ST   D13S317: 8,9

ST   D16S539: 9,10

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TALL-101

AC   CVCL_4922

DR   Cosmic; 721701

DR   Cosmic; 913408

DR   Cosmic; 933549

DR   Cosmic; 1012121

DR   Cosmic; 1115586

DR   Cosmic; 1151795

DR   Cosmic; 1330504

DR   Cosmic; 1524824

RX   PubMed=1706955;

RX   PubMed=2656885;

RX   PubMed=2953797;

RX   PubMed=3496132;

CC   Characteristics: CSF2 dependent.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TALL-103

AC   CVCL_4923

RX   PubMed=1706955;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103

CC   Characteristics: IL3 dependent.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TALL-103/2

AC   CVCL_4805

RX   PubMed=1706955;

RX   PubMed=2246514;

RX   PubMed=2351825;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103

CC   Characteristics: IL3 dependent.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4923 ! TALL-103

SX   Male

CA   Cancer cell line

//

ID   TALL-103/3

AC   CVCL_L799

RX   PubMed=1706955;

RX   PubMed=2246514;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103

CC   Characteristics: IL3 dependent.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4923 ! TALL-103

SX   Male

CA   Cancer cell line

//

ID   TALL-104

AC   CVCL_2771

DR   BTO; BTO:0003740

DR   CLO; CLO_0009267

DR   ATCC; CRL-11386

DR   BioSample; SAMN03471335

DR   CCRID; 3111C0001CCC000167

DR   Cosmic; 683541

RX   PubMed=1706955;

CC   Characteristics: IL2 dependent.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 12

ST   D5S818: 12,13

ST   D7S820: 7,13

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TALL-105

AC   CVCL_L800

RX   PubMed=1706955;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TALL-106

AC   CVCL_L801

RX   PubMed=1706955;

CC   Characteristics: IL3 dependent.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TALL-107

AC   CVCL_8464

RX   PubMed=8490180;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TalphaT1

AC   CVCL_U355

SY   T-alpha-T1

RX   PubMed=8898243;

RX   PubMed=15541569;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_U463 ! AlphaT1-1

CA   Transformed cell line

//

ID   TALS9-11.2

AC   CVCL_FA04

SY   ND50008

DR   NHCDR; ND50008

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (Mutation in C9orf72).

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   TALS9-12.3

AC   CVCL_FA05

SY   ND50009

DR   NHCDR; ND50009

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALS9-8.1

AC   CVCL_EZ97

SY   ND50002

DR   NHCDR; ND50002

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EZ98 ! TALS9-8.6

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALS9-8.6

AC   CVCL_EZ98

SY   ND50011

DR   NHCDR; ND50011

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EZ97 ! TALS9-8.1

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALS9-9.3

AC   CVCL_EZ95

SY   ND50000

DR   NHCDR; ND50000

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EZ96 ! TALS9-9.5

SX   Female

CA   Induced pluripotent stem cell

//

ID   TALS9-9.5

AC   CVCL_EZ96

SY   ND50001

DR   NHCDR; ND50001

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EZ95 ! TALS9-9.3

SX   Female

CA   Induced pluripotent stem cell

//

ID   TALSCTRL11.5

AC   CVCL_EZ99

SY   ND50003

DR   NHCDR; ND50003

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALSCTRL15.12

AC   CVCL_FA00

SY   ND50004

DR   NHCDR; ND50004

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   TALSSOD1A4V-39.7

AC   CVCL_FA06

SY   ND50010

DR   NHCDR; ND50010

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   TALSSPO16.2

AC   CVCL_FA01

SY   ND50005

DR   NHCDR; ND50005

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALSSPO21.21

AC   CVCL_FA02

SY   ND50006

DR   NHCDR; ND50006

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TALSTDP-47.10

AC   CVCL_FA03

SY   ND50007

DR   NHCDR; ND50007

WW   http://www.targetals.org/about-us/how_were_organized.html

CC   From: Target ALS Foundation; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   Talsky

AC   CVCL_DN31

RX   PubMed=26842912;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   TAM.T

AC   CVCL_4008

DR   CLO; CLO_0009268

DR   ATCC; CRL-6001

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6001; true.

OX   NCBI_TaxID=48850; ! Tamandua tetradactyla

SX   Sex undetermined

CA   Finite cell line

//

ID   TAMH

AC   CVCL_B471

DR   BTO; BTO:0004226

RX   PubMed=7525051;

CC   Breed/subspecies: CD-1 MT42 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Tank

AC   CVCL_0E95

SY   TANK

DR   ATCC; CRL-1847

RX   PubMed=1690682;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-1847; true.

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Transformed cell line

//

ID   Tanoue

AC   CVCL_1852

SY   TANOUE

DR   CLO; CLO_0009269

DR   CLO; CLO_0050979

DR   EFO; EFO_0002380

DR   BioSample; SAMN03472169

DR   BioSample; SAMN03473578

DR   Cosmic; 1012122

DR   Cosmic; 1130258

DR   Cosmic; 1281385

DR   DSMZ; ACC-399

DR   IGRhCellID; TANOUE

DR   RCB; RCB1180

RX   PubMed=7538617;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40 hours (DSMZ).

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): DSMZ; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,12 (DSMZ)

ST   D5S818: 10,11,12 (RCB)

ST   D7S820: 10,11

ST   TH01: 7,10

ST   TPOX: 11

ST   vWA: 14,19 (DSMZ)

ST   vWA: 14,18,19 (RCB)

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   tao BpRc1

AC   CVCL_3800

SY   tao BpRcl

DR   CLO; CLO_0009270

DR   ATCC; CRL-2218

CC   Breed/subspecies: C57L.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3492 ! BpRc1

SX   Female

CA   Cancer cell line

//

ID   TAOV

AC   CVCL_U987

DR   BTO; BTO:0004922

RX   PubMed=12019149;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TARL-2

AC   CVCL_0557

DR   MCCL; MCC:0000458

RX   PubMed=2880789;

RX   PubMed=6323614;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   TARS-1

AC   CVCL_D322

RX   PubMed=2880789;

RX   PubMed=2892480;

RX   PubMed=6323614;

CC   Characteristics: HTLV-1 producing cell line.

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   TART-1

AC   CVCL_D323

RX   PubMed=2880789;

RX   PubMed=6323614;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   TAS-5

AC   CVCL_8484

DR   JCRB; JCRB1370

RX   PubMed=8660794;

RX   PubMed=9893044;

CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Hybridoma

//

ID   TASK1

AC   CVCL_3177

DR   BioSample; SAMN03470806

DR   Cosmic-CLP; 1299067

DR   GDSC; 1299067

DR   GEO; GSM827197

DR   GEO; GSM1670524

DR   JCRB; JCRB0139

DR   JCRB; NIHS0202

RX   PubMed=9661044;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; NIHS0202; true.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 13

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C7542; Askin tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Tat-1

AC   CVCL_M789

RX   PubMed=11840295;

DI   NCIt; C3209; Follicular lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TAT1

AC   CVCL_T980

SY   TAT-1

DR   ECACC; 00020911

RX   PubMed=2606940;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Tau RD P301S FRET Biosensor

AC   CVCL_DA04

DR   ATCC; CRL-3275

RX   PubMed=25261551;

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 9,13

ST   D5S818: 8,9

ST   D7S820: 11

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   TAW-925

AC   CVCL_Z044

RX   PubMed=3030301;

CC   Group: Hybridoma fusion partner cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   TAYA

AC   CVCL_M717

RX   PubMed=11914605;

CC   Doubling time: 50 hours (PubMed=11914605).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TB

AC   CVCL_4Z67

RX   PubMed=10320710;

CC   Doubling time: 18 +- 2 hours (PubMed=10320710).

DI   NCIt; C6891; Meningeal melanomatosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Tb 1 Lu

AC   CVCL_2730

SY   Tb 1 Lu (NBL-12); NBL-12; TB1 Lu; TB-1 Lu; Tb1.Lu; Tb1Lu; Bat lung

DR   CLO; CLO_0009271

DR   CLO; CLO_0009272

DR   CLO; CLO_0009274

DR   CLO; CLO_0009275

DR   CLDB; cl392

DR   CLDB; cl4486

DR   CLDB; cl4487

DR   CLDB; cl4488

DR   ATCC; CCL-88

DR   ATCC; CRL-6564

DR   CCLV; CCLV-RIE 0072

DR   ECACC; 90020805

DR   ICLC; ATL96010

DR   IZSLER; BS CL 84

RX   PubMed=7065527;

RX   PubMed=19941903;

CC   Group: Bat cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6564; true.

OX   NCBI_TaxID=9438; ! Tadarida brasiliensis

SX   Female

CA   Finite cell line

//

ID   TB 28-2

AC   CVCL_F778

DR   CLO; CLO_0009273

DR   ATCC; HB-61

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   TB-6c

AC   CVCL_M351

RX   PubMed=226998;

RX   PubMed=6267945;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8386; ! Rhinella marina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TB1A2

AC   CVCL_1D84

RX   PubMed=8691151;

WW   http://www.ott.nih.gov/erma/tb1a2-cells-are-defective-protein-tyrosine-kinase-syk-immunoglobulin-ige-receptor-induced

CC   Breed/subspecies: Wistar.

DI   NCIt; C60428; Rat leukemia

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0591 ! RBL-2H3

CA   Cancer cell line

//

ID   TB2

AC   CVCL_Y570

SY   Tilapia Brain 2

RX   PubMed=18096421;

CC   Group: Fish cell line.

OX   NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TBC34836

AC   CVCL_V383

DR   IMGT/HLA; 14461

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   TBC60311

AC   CVCL_V384

DR   IMGT/HLA; 14460

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   TBCN-1

AC   CVCL_0T71

RX   PubMed=9824643;

CC   Doubling time: 54 hours (PubMed=9824643).

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TBCN-6

AC   CVCL_H710

SY   TBCN6

RX   CelloPub=CLPUB00275;

RX   PubMed=15645130;

CC   Derived from metastatic site: Liver.

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TBE-1 [Human bronchial epithelial]

AC   CVCL_R813

RX   PubMed=3975607;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   TBE-1 [Turbot]

AC   CVCL_R814

SY   TurBot Epithelial-1

RX   PubMed=8856337;

CC   Group: Fish cell line.

OX   NCBI_TaxID=52904; ! Scophthalmus maximus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TBJ

AC   CVCL_L429

RX   PubMed=8749920;

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4343 ! C-1300

SX   Male

CA   Cancer cell line

//

ID   TBK1-DEF

AC   CVCL_4W78

DR   JCRB; JCRB1535

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   TBL20

AC   CVCL_2G83

SY   TaH/BL20; TaBL 20

RX   PubMed=2421227;

RX   PubMed=7770085;

RX   PubMed=23840536;

CC   Characteristics: In vitro infected by Theileria annulata isolate Hissar.

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Holstein Friesian.

DI   NCIt; C131469; Bovine leukemia

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_L859 ! BL20

SX   Female

CA   Cancer cell line

//

ID   TBL3

AC   CVCL_2G82

SY   TaH/BL3

RX   PubMed=7770085;

CC   Characteristics: In vitro infected by Theileria annulata isolate Hissar.

CC   Breed/subspecies: Hereford.

DI   NCIt; C131469; Bovine leukemia

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_3454 ! BL-3 [Bovine leukemia]

SX   Male

CA   Cancer cell line

//

ID   TBM-54

AC   CVCL_5654

SY   TB-M

DR   CLO; CLO_0009278

DR   ATCC; CRL-2051

RX   PubMed=226998;

RX   PubMed=6267945;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8386; ! Rhinella marina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TBR-B

AC   CVCL_6A91

SY   TBRB

RX   PubMed=7796878;

RX   PubMed=10996322;

RX   PubMed=11520047;

RX   PubMed=11776976;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   TBR10-1

AC   CVCL_F961

SY   TBR 10-1; TBR10

DR   TKG; TKG 0622

RX   PubMed=9638976;

RX   PubMed=11776976;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   TBR31-1

AC   CVCL_5371

SY   TBR 31-1

RX   CelloPub=CLPUB00291;

RX   PubMed=9224657;

RX   PubMed=9638976;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6A86 ! TBR31-2

CA   Conditionally immortalized cell line

//

ID   TBR31-2

AC   CVCL_6A86

SY   TBR 31-2

RX   PubMed=7796878;

RX   PubMed=9638976;

RX   PubMed=10679225;

RX   PubMed=11520047;

RX   PubMed=11776976;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5371 ! TBR31-1

CA   Conditionally immortalized cell line

//

ID   TBR52

AC   CVCL_6A92

SY   TBR 52

RX   PubMed=7796878;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   TBR59

AC   CVCL_5372

SY   TBR 59

RX   CelloPub=CLPUB00291;

RX   PubMed=7796878;

RX   PubMed=9224657;

RX   PubMed=9638976;

RX   PubMed=10378898;

RX   PubMed=11520047;

RX   PubMed=17233813;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=TBR59

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   TC 178

AC   CVCL_N709

SY   T.C. 178; TC178; Tissue Culture 178

RX   CelloPub=CLPUB00278;

RX   PubMed=195435;

RX   PubMed=467167;

RX   PubMed=13766343;

RX   PubMed=13856118;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC 224

AC   CVCL_N710

RX   PubMed=13766343;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC 314

AC   CVCL_5H67

SY   TC314

RX   CelloPub=CLPUB00278;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC 379

AC   CVCL_5G75

SY   TC379

RX   CelloPub=CLPUB00278;

RX   PubMed=467167;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC 396

AC   CVCL_5G74

RX   CelloPub=CLPUB00278;

RX   PubMed=467167;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC 491

AC   CVCL_5G76

SY   TC491

RX   PubMed=5578746;

CC   Miscellaneous: Cell line has been lost (PubMed=5578746).

CC   Derived from metastatic site: Cerebellum.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC 501

AC   CVCL_N711

SY   TC501

RX   CelloPub=CLPUB00278;

RX   PubMed=195435;

RX   PubMed=467167;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N712 ! TC 526

SX   Male

CA   Cancer cell line

//

ID   TC 526

AC   CVCL_N712

SY   TC526

RX   CelloPub=CLPUB00278;

RX   PubMed=195435;

RX   PubMed=467167;

RX   PubMed=3288483;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N711 ! TC 501

SX   Male

CA   Cancer cell line

//

ID   TC 593

AC   CVCL_N713

SY   TC593

RX   CelloPub=CLPUB00278;

RX   PubMed=195435;

RX   PubMed=467167;

RX   PubMed=3192213;

RX   PubMed=3288483;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC 620

AC   CVCL_N714

SY   TC-620; TC620

RX   CelloPub=CLPUB00278;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=195435;

RX   PubMed=467167;

RX   PubMed=3142218;

RX   PubMed=3192213;

RX   PubMed=3288483;

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC 691

AC   CVCL_5G73

RX   CelloPub=CLPUB00278;

RX   PubMed=3288483;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-1 [Human renal carcinoma]

AC   CVCL_M349

RX   PubMed=1479760;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-1 [Mouse lung]

AC   CVCL_4699

SY   TC-1[JHU-1]; Tissue Culture-1

DR   BTO; BTO:0004795

DR   CLO; CLO_0009279

DR   ATCC; CRL-2785

DR   ATCC; JHU-1

DR   NCBI_Iran; C569

RX   PubMed=8548765;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Discontinued: ATCC; CRL-2785; true.

CC   Discontinued: ATCC; JHU-1; true.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   TC-106

AC   CVCL_F531

SY   TC106

DR   Cosmic; 2228235

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3004699;

RX   PubMed=3390826;

RX   PubMed=25010205;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Scalp.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-131

AC   CVCL_7147

SY   TC-131T

DR   Cosmic; 1091066

RX   PubMed=3004699;

RX   PubMed=7882340;

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-135

AC   CVCL_9698

SY   TC135

CC   From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-138

AC   CVCL_4Z30

DR   Cosmic; 2228236

RX   PubMed=25010205;

WW   http://www.cogcell.org/cellreqs-eft.php

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-174

AC   CVCL_7148

DR   Cosmic; 1091067

RX   PubMed=7882340;

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC-205

AC   CVCL_4Z31

DR   Cosmic; 2228237

RX   PubMed=25010205;

WW   http://www.cogcell.org/cellreqs-eft.php

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-206

AC   CVCL_7149

DR   Cosmic; 1091068

RX   PubMed=7882340;

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-212

AC   CVCL_S867

SY   TC212

RX   PubMed=23882450;

CC   From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11,13

ST   D16S539: 11,14

ST   D18S51: 12,16

ST   D19S433: 13

ST   D21S11: 30

ST   D2S1338: 19,20

ST   D3S1358: 16,18

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   D8S1179: 10,11

ST   FGA: 20,24

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-215

AC   CVCL_4Z32

DR   Cosmic; 2228238

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-240

AC   CVCL_4Z33

DR   Cosmic; 2228239

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-244

AC   CVCL_4Z34

DR   Cosmic; 2228240

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-248

AC   CVCL_4Z35

SY   TC248

DR   Cosmic; 2228241

RX   PubMed=25010205;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-249

AC   CVCL_4Z36

DR   Cosmic; 2228242

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-252

AC   CVCL_S866

SY   TC 252; TC252

DR   Cosmic; 2060802

CC   From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-253

AC   CVCL_7150

DR   Cosmic; 1091070

DR   Cosmic; 2228243

RX   PubMed=7882340;

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-268

AC   CVCL_F532

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2841669;

RX   PubMed=8577710;

DI   NCIt; C3789; Olfactory neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC-280

AC   CVCL_S871

CC   From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC-32

AC   CVCL_7151

SY   TC32

DR   BTO; BTO:0004227

DR   CCLE; TC32_BONE

DR   Cosmic; 759891

DR   Cosmic; 1078387

DR   Cosmic; 1084513

DR   Cosmic; 1718432

DR   Cosmic; 2060803

DR   Cosmic; 2228244

DR   Cosmic; 2294588

DR   GEO; GSM1676322

DR   GEO; GSM1701655

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3004699;

RX   PubMed=3390826;

RX   PubMed=16631476;

RX   PubMed=24312454;

RX   PubMed=25010205;

RX   PubMed=25984343;

RX   PubMed=26351324;

RX   PubMed=28196595;

WW   http://www.cogcell.org/dl/EFT_Lines_DataSheets/TC-32_Cell_Line_Data_Sheet_COGcell_org.pdf

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 36 hours (PubMed=25984343).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=24312454

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 10,12

ST   D16S539: 13,14

ST   D18S51: 11,19

ST   D19S433: 12,14

ST   D21S11: 27,28

ST   D2S1338: 17,19

ST   D3S1358: 15,16

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   D8S1179: 12

ST   FGA: 23,24

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 15,18

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC-4C

AC   CVCL_4Z37

DR   Cosmic; 2228245

RX   PubMed=25010205;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-71

AC   CVCL_2213

SY   TC71; GM11654

DR   BTO; BTO:0002604

DR   CLO; CLO_0021329

DR   EFO; EFO_0002865

DR   BioSample; SAMN03473241

DR   CCLE; TC71_BONE

DR   Coriell; GM11654

DR   Cosmic; 1078383

DR   Cosmic; 1082507

DR   Cosmic; 1112132

DR   Cosmic; 1718433

DR   Cosmic; 2228246

DR   Cosmic; 2250474

DR   Cosmic; 2294589

DR   Cosmic-CLP; 1240221

DR   DSMZ; ACC-516

DR   GDSC; 1240221

DR   GEO; GSM510013

DR   GEO; GSM887689

DR   GEO; GSM888781

DR   GEO; GSM1670525

DR   GEO; GSM1676323

DR   GEO; GSM1701656

RX   PubMed=3004699;

RX   PubMed=3390826;

RX   PubMed=8617485;

RX   PubMed=15150091;

RX   PubMed=19787792;

RX   PubMed=22460905;

RX   PubMed=24312454;

RX   PubMed=25010205;

RX   PubMed=25223734;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.cogcell.org/dl/EFT_Lines_DataSheets/TC-71_Cell_Line_Data_Sheet_COGcell_org.pdf

WW   http://www.cogcell.org/cellreqs-ncipptp.php

WW   http://www.pptpinvitro.org/cell_lines_panel.php

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.

CC   Doubling time: 26 hours (PubMed=25984343); ~24 hours (DSMZ); 21 hours (COG).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): COG; Cosmic-CLP; DSMZ; PubMed=24312454; PubMed=25877200

ST   Amelogenin: X,Y (Cosmic-CLP; COG; PubMed=24312454)

ST   Amelogenin: X (DSMZ; PubMed=25877200)

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11,14

ST   D18S51: 12,15

ST   D19S433: 14,16.2

ST   D21S11: 29,30

ST   D2S1338: 20,24

ST   D3S1358: 15,17

ST   D5S818: 10

ST   D7S820: 10

ST   D8S1179: 10,12

ST   FGA: 24,26

ST   Penta D: 11,14

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 17 (COG; DSMZ; PubMed=24312454; PubMed=25877200)

ST   vWA: 17,19 (Cosmic-CLP)

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC-78

AC   CVCL_Y006

SY   TC78

RX   PubMed=2474371;

RX   PubMed=9177455;

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TC-83

AC   CVCL_9716

CC   From: Van Valen F.; University of Munster; Germany.

DI   NCIt; C7542; Askin tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC-YIK

AC   CVCL_1737

DR   CLO; CLO_0050913

DR   BioSample; SAMN03472316

DR   ChEMBL-Cells; CHEMBL3308250

DR   ChEMBL-Targets; CHEMBL2366324

DR   Cosmic; 946357

DR   Cosmic; 1995659

DR   Cosmic-CLP; 946357

DR   GDSC; 946357

DR   GEO; GSM1670527

DR   RCB; RCB0443

RX   PubMed=1849445;

RX   PubMed=10391092;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 9,11

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C7982; Cervical small cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC1 [Mouse ESC]

AC   CVCL_M350

SY   TC-1

DR   BTO; BTO:0004888

RX   PubMed=8601314;

CC   Breed/subspecies: 129S6/SvEvTacfBR.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   TC1 [Mouse hybridoma]

AC   CVCL_G561

SY   TC-1

DR   ATCC; CRL-2493

RX   PubMed=6425217;

CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa eta.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   TC10

AC   CVCL_0558

DR   MCCL; MCC:0000459

RX   PubMed=8274453;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   TC106

AC   CVCL_F720

DR   IMGT/HLA; 11433

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   TC289

AC   CVCL_IS68

RX   PubMed=11557780;

RX   PubMed=16557275;

DI   NCIt; C8715; Rhabdoid tumor of the kidney

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TC31

AC   CVCL_G562

SY   TC-31; TC-31.4

DR   ATCC; CRL-2494

RX   PubMed=6425217;

CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa eta.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   TC6

AC   CVCL_6A95

SY   TC 6; T immortalized chondrocyte-like cell 6

RX   PubMed=8915772;

RX   PubMed=9224657;

RX   PubMed=10502305;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   TC620.6A2

AC   CVCL_5G72

RX   PubMed=3142218;

RX   PubMed=8530186;

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_N714 ! TC 620

CA   Cancer cell line

//

ID   TC7

AC   CVCL_S881

DR   Cosmic; 711260

DR   Cosmic; 887224

RX   PubMed=9000572;

RX   PubMed=10732766;

RX   PubMed=11526487;

RX   PubMed=24042735;

CC   Microsatellite instability: Instable (MSI) (PubMed=9000572).

CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.

ST   Source(s): PubMed=24042735

ST   Amelogenin: X

ST   CSF1PO: 9,14

ST   D13S317: 8,10,11

ST   D16S539: 10,11

ST   D18S51: 16,17,18

ST   D19S433: 12,15

ST   D21S11: 29,30

ST   D2S1338: 21,23

ST   D3S1358: 13,17

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 11,12

ST   FGA: 21,25

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TC71

AC   CVCL_S882

DR   Cosmic; 711259

DR   Cosmic; 887221

DR   Cosmic; 1132567

DR   Cosmic; 1479584

RX   PubMed=9000572;

RX   PubMed=10732766;

RX   PubMed=11526487;

RX   PubMed=24042735;

CC   Microsatellite instability: Instable (MSI) (PubMed=9000572; PubMed=24042735).

CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.

ST   Source(s): PubMed=24042735

ST   Amelogenin: X

ST   CSF1PO: 10,15

ST   D13S317: 9,12,13

ST   D16S539: 11

ST   D18S51: 10,11,15

ST   D19S433: 13

ST   D21S11: 29,32.2

ST   D2S1338: 16,17

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 12

ST   D8S1179: 10,13

ST   FGA: 18,19

ST   TH01: 7,8

ST   TPOX: 9,11

ST   vWA: 14,17

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Tc81

AC   CVCL_Z277

RX   PubMed=23535851;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7070; ! Tribolium castaneum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Tca8113

AC   CVCL_6851

SY   TCA8113; Tca-8113

DR   CCRID; 3111C0001CCC000296

DR   CCRID; 3131C0001000700077

DR   CCRID; 3142C0001000000067

DR   CCRID; 3153C0001000000014

DR   Cosmic; 851222

DR   KCB; KCB 93034YJ

RX   PubMed=3464389;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Tca8113-P160

AC   CVCL_7906

SY   Tca8113P160

DR   CCRID; 3142C0001000000142

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   Tca8113-P60

AC   CVCL_7907

SY   Tca8113P60

DR   CCRID; 3142C0001000000141

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   Tca8113/CBP [Chengdu]

AC   CVCL_9U53

RX   PubMed=21365850;

CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   Tca8113/CBP [Chongqing]

AC   CVCL_T058

RX   CelloPub=CLPUB00004;

CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   Tca8113/PYM [Changsha]

AC   CVCL_9U54

RX   DOI=10.1016/j.cellbi.2008.01.124;

RX   PubMed=21040473;

CC   Selected for resistance to: ChEBI; CHEBI:78160; Bleomycin A5 (Pingyangmycin).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   Tca8113/PYM [Chengdu]

AC   CVCL_9U55

RX   PubMed=21365850;

CC   Selected for resistance to: ChEBI; CHEBI:78160; Bleomycin A5 (Pingyangmycin).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6851 ! Tca8113

SX   Female

CA   Cancer cell line

//

ID   TCAF

AC   CVCL_K592

DR   ChEMBL-Cells; CHEMBL3307350

DR   ChEMBL-Targets; CHEMBL614244

DI   NCIt; C3183; T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TCAF-DAX

AC   CVCL_K692

SY   TCAFDAX

DR   ChEMBL-Cells; CHEMBL3307465

DR   ChEMBL-Targets; CHEMBL615009

DI   NCIt; C3183; T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_K592 ! TCAF

CA   Cancer cell line

//

ID   TCam-2

AC   CVCL_T012

SY   TCAM-2; TCam 2

DR   Cosmic; 1449155

DR   Cosmic; 2077183

DR   Cosmic; 2163764

RX   PubMed=8394948;

RX   PubMed=18008088;

RX   PubMed=20607849;

RX   PubMed=21668453;

RX   PubMed=24812411;

DI   NCIt; C7328; Testicular seminoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TCC-MESO-1

AC   CVCL_E263

RX   PubMed=19876922;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E264 ! TCC-MESO-2

SX   Male

CA   Cancer cell line

//

ID   TCC-MESO-2

AC   CVCL_E264

RX   PubMed=19876922;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E263 ! TCC-MESO-1

SX   Male

CA   Cancer cell line

//

ID   TCC-MESO-3

AC   CVCL_E265

RX   PubMed=19876922;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TCC-PAN2

AC   CVCL_3178

SY   TCC-Pan2

DR   EFO; EFO_0006764

DR   BioSample; SAMN03472903

DR   CCLE; TCCPAN2_PANCREAS

DR   GEO; GSM887690

DR   GEO; GSM888782

DR   GEO; GSM1588616

DR   JCRB; JCRB1072

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11

ST   D18S51: 16

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   D8S1179: 13,16

ST   FGA: 20

ST   Penta D: 10

ST   Penta E: 19

ST   TH01: 6,7

ST   TPOX: 11,12

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TCC-S

AC   CVCL_W386

RX   PubMed=16130897;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TCCSUP

AC   CVCL_1738

SY   TCCSuP; TCC-SUP; TCC Sup

DR   CLO; CLO_0009283

DR   ATCC; HTB-5

DR   BioSample; SAMN03472747

DR   BioSample; SAMN03473325

DR   CCLE; TCCSUP_URINARY_TRACT

DR   ChEMBL-Cells; CHEMBL3307466

DR   ChEMBL-Targets; CHEMBL615010

DR   Cosmic; 687459

DR   Cosmic; 755398

DR   Cosmic; 925833

DR   Cosmic; 943734

DR   Cosmic; 1046692

DR   Cosmic; 1285131

DR   Cosmic; 1286003

DR   Cosmic; 2037961

DR   Cosmic; 2050466

DR   Cosmic; 2057460

DR   Cosmic; 2444246

DR   Cosmic-CLP; 687459

DR   DSMZ; ACC-377

DR   GDSC; 687459

DR   GEO; GSM142308

DR   GEO; GSM142311

DR   GEO; GSM142312

DR   GEO; GSM827282

DR   GEO; GSM888783

DR   GEO; GSM1374955

DR   GEO; GSM1374956

DR   GEO; GSM1574563

DR   GEO; GSM1670526

RX   PubMed=836756;

RX   PubMed=3708594;

RX   PubMed=6244232;

RX   PubMed=6582512;

RX   PubMed=6826254;

RX   PubMed=22460905;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25984343;

RX   PubMed=25997541;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: 46 hours (PubMed=25984343); ~30-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'JCCSUP' in PubMed=6582512.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=11416159

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,14 (ATCC; Cosmic-CLP)

ST   D13S317: 11 (DSMZ)

ST   D16S539: 9,11

ST   D18S51: 15

ST   D21S11: 27,31.2

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 13

ST   FGA: 21

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TcHMC-1

AC   CVCL_H204

RX   PubMed=3488124;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   TCL-1

AC   CVCL_5373

SY   Trophoblast Cell Line-1

RX   PubMed=8730883;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=TCL-1

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ZipSV40-6].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   TCL-As

AC   CVCL_G008

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F909 ! ILT-As

SX   Male

CA   Transformed cell line

//

ID   TCL-Haz

AC   CVCL_G009

RX   PubMed=6088403;

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   TCL-Kan

AC   CVCL_G010

DR   TKG; TKG 0285

RX   PubMed=6088403;

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   TCL-Mor

AC   CVCL_G011

RX   PubMed=6088403;

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F910 ! ILT-Mor

OI   CVCL_0074 ! TL-Mor

SX   Male

CA   Transformed cell line

//

ID   TCL-Na1

AC   CVCL_6852

SY   TCL-NA1; TCLNa1; Na1

RX   PubMed=2981920;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=Na1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   TCL-Ter

AC   CVCL_G012

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F914 ! ILT-Ter

SX   Male

CA   Transformed cell line

//

ID   TCMK-1

AC   CVCL_2772

SY   TCMK1; Transformed C3H Mouse Kidney-1

DR   BTO; BTO:0004231

DR   CLO; CLO_0009284

DR   CLDB; cl4493

DR   ATCC; CCL-139

DR   ECACC; 90050802

DR   KCLB; 10139

RX   PubMed=14120333;

RX   PubMed=14206435;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].

CC   Discontinued: ECACC; 90050802; probable.

CC   Breed/subspecies: C3H/Mai.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   TCNT1

AC   CVCL_K095

DR   RCB; AES0127

DR   RCB; RCB2701

CC   Discontinued: RCB; RCB2701; true.

CC   Breed/subspecies: C57BL/6 x 129.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   TCO

AC   CVCL_HE32

DR   Cosmic; 905004

RX   PubMed=7601562;

RX   PubMed=15729718;

CC   Derived from metastatic site: Not specified.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TCO-1 [Human cervical carcinoma]

AC   CVCL_3179

DR   BioSample; SAMN03151962

DR   ChEMBL-Cells; CHEMBL3308791

DR   ChEMBL-Targets; CHEMBL1075599

DR   Cosmic; 877475

DR   Cosmic; 1152549

DR   RCB; RCB0640

RX   PubMed=1607768;

RX   PubMed=16643607;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a TCS derivative (PubMed=16643607, PubMed=20143388).

CC   Discontinued: RCB; RCB0640; true.

DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8160 ! TCS

SX   Female

CA   Cancer cell line

//

ID   TCO-1 [Human thyroid carcinoma]

AC   CVCL_M839

SY   TCO-I

DR   BioSample; SAMN03471663

DR   CGH-DB; 59-1

DR   Cosmic; 909763

DR   Cosmic; 2054090

DR   GEO; GSM827182

DR   JCRB; JCRB0239

RX   PubMed=2181436;

RX   PubMed=9177455;

RX   PubMed=9290701;

RX   PubMed=16924234;

RX   PubMed=23833040;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,13

ST   D5S818: 11

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 12

ST   vWA: 17,19

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TCO-2

AC   CVCL_3630

DR   CLO; CLO_0050920

DR   BioSample; SAMN03472216

DR   Cosmic; 877476

DR   Cosmic; 1152550

DR   RCB; RCB0689

RX   PubMed=1607768;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 9,12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,19,20

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TCO-4

AC   CVCL_M840

RX   PubMed=2181436;

DI   NCIt; C4815; Thyroid gland carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   tCPC-12

AC   CVCL_0E88

SY   tCPC 12; tCPC clone 12

RX   PubMed=10973559;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   tCPC-B

AC   CVCL_0E89

SY   tCPC B; tCPC clone B

RX   PubMed=10973559;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   tCPC-C

AC   CVCL_0E90

SY   tCPC C; tCPC clone C

RX   PubMed=10973559;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   tCPC-D

AC   CVCL_0E91

SY   tCPC D; tCPC clone D

RX   PubMed=10973559;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   TCS

AC   CVCL_8160

SY   TC-S

DR   CLO; CLO_0050938

DR   BioSample; SAMN03472262

DR   RCB; RCB0638

RX   PubMed=6520483;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12,13

ST   D13S317: 8,10,11

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 11,12,13

ST   TH01: 7

ST   TPOX: 8,11,12

ST   vWA: 14,18,19

DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TD

AC   CVCL_5M22

RX   PubMed=4735239;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_5M20 ! KF

OI   CVCL_5M21 ! MB

OI   CVCL_5M23 ! WE

CA   Cancer cell line

//

ID   TD.1

AC   CVCL_F779

DR   CLO; CLO_0009285

DR   ATCC; CRL-2232

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   TDL-1

AC   CVCL_8428

DR   BioSample; SAMN03151883

RX   PubMed=6248453;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2676 ! P3HR-1

SX   Male

CA   Cancer cell line

//

ID   TDL-2

AC   CVCL_8429

DR   BioSample; SAMN03151884

RX   PubMed=6248453;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2676 ! P3HR-1

SX   Male

CA   Cancer cell line

//

ID   TDL-3

AC   CVCL_8430

DR   BioSample; SAMN03151909

RX   PubMed=6248453;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a RPMI-1788 derivative (PubMed=6248453, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2710 ! RPMI-1788

SX   Male

CA   Transformed cell line

//

ID   TDL-4

AC   CVCL_8431

DR   BioSample; SAMN03151900

RX   PubMed=6248453;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Raji derivative (PubMed=6248453, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0511 ! Raji

SX   Male

CA   Cancer cell line

//

ID   TDMM1

AC   CVCL_GS49

RX   PubMed=15160996;

CC   From: Takahashi; Japanese Red Cross Medical Center; Tokyo; Japan.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TE 112.T

AC   CVCL_S335

DR   ATCC; CRL-7742

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7742; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Undefined cell line type

//

ID   TE 114.T

AC   CVCL_S336

DR   ATCC; CRL-7743

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7743; true.

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 115.T

AC   CVCL_1739

DR   CLO; CLO_0009288

DR   ATCC; CRL-7744

DR   BioSample; SAMN03471144

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   TE 125.T

AC   CVCL_1740

DR   CLO; CLO_0009289

DR   ATCC; CRL-7945

DR   ATCC; CRL-7945_FL

DR   CCLE; TE125T_SOFT_TISSUE

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7945; true.

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 127.T

AC   CVCL_S337

DR   ATCC; CRL-7745

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7745; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Undefined cell line type

//

ID   TE 130.T

AC   CVCL_1741

DR   CLO; CLO_0009290

DR   ATCC; CRL-7746

DR   BioSample; SAMN03471145

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13,14

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 10,13

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C99055; Sacrococcygeal teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 131.T

AC   CVCL_S338

DR   ATCC; CRL-7747

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7747; true.

DI   NCIt; C3211; Non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 138.T

AC   CVCL_S262

DR   ATCC; CRL-7946

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7946; true.

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 139.T

AC   CVCL_S339

DR   ATCC; CRL-7748

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7748; true.

DI   NCIt; C3403; Teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 141.T

AC   CVCL_S340

DR   ATCC; CRL-7749

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7749; true.

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 143.T

AC   CVCL_S341

DR   ATCC; CRL-7750

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7750; true.

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 149.T

AC   CVCL_1742

DR   CLO; CLO_0009291

DR   ATCC; CRL-7751

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7751; true.

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 159.T

AC   CVCL_1743

SY   TE-159-T

DR   CLO; CLO_0009292

DR   ATCC; CRL-7752

DR   BioSample; SAMN03471147

DR   CCLE; TE159T_SOFT_TISSUE

DR   Cosmic; 686755

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12,14

ST   D16S539: 9,11

ST   D5S818: 9,11

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 161.T

AC   CVCL_1744

SY   TE-161-T

DR   CLO; CLO_0009293

DR   ATCC; CRL-7753

DR   BioSample; SAMN03471146

DR   Cosmic; 909765

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7753; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 8,11

ST   D5S818: 12,13

ST   D7S820: 8

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 170.M

AC   CVCL_1745

DR   CLO; CLO_0009294

DR   ATCC; CRL-7754

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7754; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   TE 175.T

AC   CVCL_1746

SY   TE-175-T

DR   CLO; CLO_0009295

DR   ATCC; CRL-7755

DR   Cosmic; 683662

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7755; true.

DI   NCIt; C3211; Non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 189.T

AC   CVCL_S261

DR   ATCC; CRL-7947

DR   BioSample; SAMN03471128

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7947; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 193.T

AC   CVCL_S403

DR   ATCC; CRL-7756

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7756; true.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 199.T

AC   CVCL_1747

DR   CLO; CLO_0009296

DR   ATCC; CRL-7757

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7757; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Undefined cell line type

//

ID   TE 206.T

AC   CVCL_1748

SY   TE-206-T

DR   CLO; CLO_0009297

DR   ATCC; CRL-7758

DR   Cosmic; 688124

DR   Cosmic; 909766

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7758; true.

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 210.T

AC   CVCL_N531

DR   ATCC; CRL-7759

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7759; true.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 211.T

AC   CVCL_N532

DR   ATCC; CRL-7760

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7760; true.

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 353.Sk

AC   CVCL_1749

SY   TE 353.SK

DR   BTO; BTO:0005290

DR   CLO; CLO_0009298

DR   ATCC; CRL-7761

DR   BioSample; SAMN03471149

RX   PubMed=21517135;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 11,14

ST   D16S539: 12

ST   D5S818: 10,13

ST   D7S820: 10

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1750 ! TE 354.T

SX   Female

CA   Finite cell line

//

ID   TE 354.T

AC   CVCL_1750

SY   TE354.T; TE354T

DR   CLO; CLO_0009299

DR   ATCC; CRL-7762

DR   BCRJ; 0290

RX   PubMed=21517135;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: BCRJ; 0290; probable.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 11,14

ST   D16S539: 12

ST   D5S818: 10,13

ST   D7S820: 10

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 14,17

DI   NCIt; C2921; Skin basal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1749 ! TE 353.Sk

SX   Female

CA   Cancer cell line

//

ID   TE 381.T

AC   CVCL_1751

SY   TE-381-T; TE381T; RD114-B

DR   CLO; CLO_0009300

DR   ATCC; CRL-7763

DR   Cosmic; 1309332

DR   IGRhCellID; TE381T

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 10,11

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 18

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 415.T

AC   CVCL_N279

DR   ATCC; CRL-7764

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7764; true.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 417.T

AC   CVCL_1752

DR   CLO; CLO_0009301

DR   ATCC; CRL-7765

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7765; true.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 418.T

AC   CVCL_1753

DR   CLO; CLO_0009302

DR   ATCC; CRL-7766

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7766; true.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 441.T

AC   CVCL_1754

SY   TE-441-T

DR   CLO; CLO_0009303

DR   ATCC; CRL-7767

DR   BioSample; SAMN03471150

DR   CCLE; TE441T_SOFT_TISSUE

DR   ChEMBL-Cells; CHEMBL3308304

DR   ChEMBL-Targets; CHEMBL2366268

DR   Cosmic; 687966

DR   Cosmic; 924248

DR   Cosmic; 1309327

DR   Cosmic-CLP; 924248

DR   GDSC; 924248

DR   GEO; GSM887696

DR   GEO; GSM888789

DR   GEO; GSM1670534

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 7,8

ST   vWA: 15,16

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 449.T

AC   CVCL_N603

DR   ATCC; CRL-7948

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7948; true.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 453.T

AC   CVCL_S397

DR   ATCC; CRL-7768

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7768; true.

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 491.T

AC   CVCL_S395

DR   ATCC; CRL-7769

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7769; true.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 501.T

AC   CVCL_S394

DR   ATCC; CRL-7770

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7770; true.

DI   NCIt; C3167; Acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 543.T

AC   CVCL_S396

DR   ATCC; CRL-7771

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7771; true.

DI   NCIt; C3211; Non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 567.T

AC   CVCL_S404

DR   ATCC; CRL-7772

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7772; true.

DI   NCIt; C99055; Sacrococcygeal teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 585.T

AC   CVCL_S260

DR   ATCC; CRL-7949

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7949; true.

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 596.T

AC   CVCL_S259

DR   ATCC; CRL-7950

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7950; true.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE 615.T

AC   CVCL_S098

DR   ATCC; CRL-7773

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7773; true.

DI   NCIt; C3790; Ganglioneuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 617.T

AC   CVCL_1755

SY   TE-617-T; TE617T

DR   CLO; CLO_0009304

DR   ATCC; CRL-7774

DR   BioSample; SAMN03471151

DR   CCLE; TE617T_SOFT_TISSUE

DR   Cosmic; 1309328

DR   GEO; GSM219749

DR   GEO; GSM887699

DR   GEO; GSM888792

RX   PubMed=19235922;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-7774; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,13

ST   D16S539: 13

ST   D5S818: 9,13

ST   D7S820: 9,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 671

AC   CVCL_1756

SY   TE-671; TE671; TE671/RD

DR   BTO; BTO:0002605

DR   CLO; CLO_0009305

DR   CLO; CLO_0009317

DR   CLDB; cl4495

DR   CLDB; cl4496

DR   CLDB; cl4497

DR   ATCC; HTB-139

DR   BioSample; SAMN03151901

DR   ChEMBL-Cells; CHEMBL3307468

DR   ChEMBL-Targets; CHEMBL615012

DR   CLS; 300355/p805_TE-671

DR   Cosmic; 970091

DR   DSMZ; ACC-263

DR   ECACC; 89071904

DR   IZSLER; BS TCL 64

DR   NCBI_Iran; C436

RX   PubMed=892931;

RX   PubMed=2650908;

RX   PubMed=2911385;

RX   PubMed=2739733;

RX   PubMed=20143388;

RX   PubMed=24335698;

WW   http://www.atcc.org/support/faqs/261cb/TE671%20ATCC%20HTB139-1062.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a RD derivative (PubMed=2650908, PubMed=2739733, PubMed=2911385, PubMed=20143388).

CC   Doubling time: ~70-80 hours (DSMZ).

CC   Discontinued: ATCC; HTB-139; true.

CC   Discontinued: ECACC; 89071904; true.

ST   Source(s): ATCC; CLS; DSMZ; PubMed=11416159

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 10,11

ST   D18S51: 13

ST   D21S11: 28,29

ST   D3S1358: 15,17

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   D8S1179: 11,15

ST   FGA: 20,21

ST   Penta D: 11,13

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 18

DI   NCIt; C8971; Embryonal rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1649 ! RD

SX   Female

CA   Cancer cell line

//

ID   TE 671 Subline No.2

AC   CVCL_2731

SY   TE671 Subline No.2; TE671 Subline 2; TE671 Line, subline 2

DR   CLO; CLO_0009318

DR   CLDB; cl4499

DR   CLDB; cl4500

DR   ATCC; CRL-8805

DR   BioSample; SAMN03151902

DR   CCRID; 3111C0001CCC000266

DR   ECACC; 94052610

DR   ICLC; HTL97021

DR   KCLB; 28805

RX   Patent=US4789640;

RX   PubMed=2911385;

RX   PubMed=2739733;

RX   PubMed=20143388;

WW   http://www.atcc.org/support/faqs/4eecc/TE671%20sub%20line%202%20ATCC%20CRL8805-1063.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733, PubMed=20143388).

CC   Discontinued: ECACC; 94052610; probable.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 10,11

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 18

DI   NCIt; C8971; Embryonal rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1756 ! TE 671

SX   Female

CA   Cancer cell line

//

ID   TE 76.T

AC   CVCL_1757

DR   CLO; CLO_0009306

DR   ATCC; CRL-7732

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7732; true.

DI   NCIt; C99055; Sacrococcygeal teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 79.T

AC   CVCL_S333

DR   ATCC; CRL-7733

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7733; true.

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 84.T

AC   CVCL_1758

DR   CLO; CLO_0009307

DR   ATCC; CRL-7944

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7944; true.

DI   NCIt; C8110; Ovarian teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 86.T

AC   CVCL_S334

DR   ATCC; CRL-7736

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7736; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Undefined cell line type

//

ID   TE 87.T

AC   CVCL_N533

DR   ATCC; CRL-7737

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7737; true.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 89.T

AC   CVCL_N535

SY   TE-89

DR   ATCC; CRL-7738

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7738; true.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE 90.Sk

AC   CVCL_2775

DR   CLO; CLO_0009308

DR   ATCC; CRL-7739

DR   BioSample; SAMN03471143

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Misspelling: 'TE9OSK' in BioSample SAMN03471143.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 11,13

ST   D5S818: 11

ST   D7S820: 8,10

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   TE 91.Sk

AC   CVCL_2773

DR   CLO; CLO_0009309

DR   ATCC; CRL-7740

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7740; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   TE 98.T

AC   CVCL_2774

DR   CLO; CLO_0009310

DR   ATCC; CRL-7741

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7741; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Undefined cell line type

//

ID   Te Ger

AC   CVCL_U793

SY   XPKABE

DR   ATCC; CRL-1275

CC   Discontinued: ATCC; CRL-1275; true.

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Te Jes

AC   CVCL_U671

SY   XP14BE

DR   ATCC; CRL-1311

CC   Discontinued: ATCC; CRL-1311; true.

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Te Ko

AC   CVCL_U669

SY   TeKo; XP7BE; XP7 BE; GM02590

DR   ATCC; CRL-1200

DR   Coriell; GM02590

DR   JCRB; KURB1072

CC   Discontinued: ATCC; CRL-1200; probable.

CC   Discontinued: Coriell; GM02590; probable.

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7359 ! GM02485

SX   Female

CA   Finite cell line

//

ID   TE-1

AC   CVCL_1759

SY   TE1

DR   BTO; BTO:0004601

DR   CLO; CLO_0051369

DR   BCRJ; 0371

DR   BioSample; SAMN03472084

DR   CCLE; TE1_OESOPHAGUS

DR   CCRID; 3131C0001000700089

DR   CGH-DB; 305-1

DR   CGH-DB; 9254-4

DR   ChEMBL-Cells; CHEMBL3308178

DR   ChEMBL-Targets; CHEMBL2366092

DR   Cosmic; 730296

DR   Cosmic; 735780

DR   Cosmic; 753621

DR   Cosmic; 801322

DR   Cosmic; 923173

DR   Cosmic; 926097

DR   Cosmic; 983713

DR   Cosmic; 1043226

DR   Cosmic; 1123318

DR   Cosmic; 1612896

DR   Cosmic-CLP; 753621

DR   GDSC; 753621

DR   GEO; GSM301571

DR   GEO; GSM887695

DR   GEO; GSM888788

DR   GEO; GSM1670528

DR   KCB; KCB 200737YJ

DR   RCB; RCB1894

DR   TKG; TKG 0252

RX   PubMed=520749;

RX   PubMed=1778766;

RX   PubMed=2990217;

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28224081;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 60 hours (PubMed=520749).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 10,11 (Cosmic-CLP; RCB)

ST   D7S820: 11 (TKG)

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-10

AC   CVCL_1760

SY   TE10

DR   CLO; CLO_0051372

DR   BioSample; SAMN03472062

DR   CCLE; TE10_OESOPHAGUS

DR   CCRID; 3131C0001000700090

DR   CGH-DB; 313-1

DR   CGH-DB; 9262-4

DR   ChEMBL-Cells; CHEMBL3308218

DR   ChEMBL-Targets; CHEMBL2366308

DR   Cosmic; 730351

DR   Cosmic; 753622

DR   Cosmic; 735789

DR   Cosmic; 923179

DR   Cosmic; 926106

DR   Cosmic; 947598

DR   Cosmic; 983722

DR   Cosmic; 1043232

DR   Cosmic; 1123327

DR   Cosmic; 1571760

DR   Cosmic; 1608836

DR   Cosmic-CLP; 753622

DR   GDSC; 753622

DR   GEO; GSM887691

DR   GEO; GSM888784

DR   GEO; GSM1374957

DR   GEO; GSM1670529

DR   RCB; RCB2099

DR   TKG; TKG 0261

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 30 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 8,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-11

AC   CVCL_1761

SY   TE11; Te11

DR   CLO; CLO_0051373

DR   BioSample; SAMN03472004

DR   CCLE; TE11_OESOPHAGUS

DR   CCRID; 3131C0001000700091

DR   CGH-DB; 314-1

DR   CGH-DB; 9263-4

DR   ChEMBL-Cells; CHEMBL3308219

DR   ChEMBL-Targets; CHEMBL2366166

DR   Cosmic; 735827

DR   Cosmic; 923180

DR   Cosmic; 926107

DR   Cosmic; 946354

DR   Cosmic; 947599

DR   Cosmic; 1043233

DR   Cosmic; 1123328

DR   Cosmic; 1571761

DR   Cosmic-CLP; 946354

DR   GDSC; 946354

DR   GEO; GSM887692

DR   GEO; GSM888785

DR   GEO; GSM1670530

DR   PRIDE; PXD002486

DR   RCB; RCB2100

DR   TKG; TKG 0262

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 10

ST   D16S539: 10,11

ST   D5S818: 8,14

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-12

AC   CVCL_1762

SY   TE12

DR   BioSample; SAMN03151963

DR   ChEMBL-Cells; CHEMBL3308220

DR   ChEMBL-Targets; CHEMBL2366278

DR   Cosmic; 735790

DR   Cosmic; 801329

DR   Cosmic; 923181

DR   Cosmic; 926108

DR   Cosmic; 946356

DR   Cosmic; 947600

DR   Cosmic; 1043234

DR   Cosmic; 1123329

DR   Cosmic-CLP; 946356

DR   GDSC; 946356

DR   GEO; GSM1374958

DR   GEO; GSM1670531

DR   TKG; TKG 0263

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=17804709;

RX   PubMed=20143388;

RX   PubMed=27397505;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: TKG; TKG 0263; probable.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 9,10

ST   D5S818: 11

ST   D7S820: 10,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4455 ! TE-2

OI   CVCL_9971 ! TE-3

OI   CVCL_9972 ! TE-7

OI   CVCL_4463 ! TE-13

SX   Male

CA   Cancer cell line

//

ID   TE-13

AC   CVCL_4463

SY   TE13

DR   BTO; BTO:0004599

DR   BioSample; SAMN03151964

DR   CGH-DB; 315-1

DR   CGH-DB; 9264-4

DR   Cosmic; 730362

DR   Cosmic; 735791

DR   Cosmic; 923182

DR   Cosmic; 926109

DR   Cosmic; 947601

DR   Cosmic; 1043235

DR   Cosmic; 1123330

DR   Cosmic; 1612899

DR   TKG; TKG 0264

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).

CC   Discontinued: TKG; TKG 0264; probable.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4455 ! TE-2

OI   CVCL_9971 ! TE-3

OI   CVCL_9972 ! TE-7

OI   CVCL_1762 ! TE-12

SX   Male

CA   Cancer cell line

//

ID   TE-14

AC   CVCL_3336

SY   TE14

DR   CLO; CLO_0051374

DR   BioSample; SAMN03472005

DR   CCLE; TE14_OESOPHAGUS

DR   CGH-DB; 316-1

DR   Cosmic; 983723

DR   Cosmic; 1043236

DR   Cosmic; 1123331

DR   GEO; GSM887693

DR   GEO; GSM888786

DR   RCB; RCB2101

DR   TKG; TKG 0265

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 10

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 19

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-15

AC   CVCL_1763

SY   TE15; Te15

DR   BTO; BTO:0004598

DR   CLO; CLO_0051370

DR   BioSample; SAMN03472042

DR   CCLE; TE15_OESOPHAGUS

DR   CGH-DB; 317-1

DR   CGH-DB; 9266-4

DR   ChEMBL-Cells; CHEMBL3308221

DR   ChEMBL-Targets; CHEMBL2366086

DR   Cosmic; 753614

DR   Cosmic; 923183

DR   Cosmic; 983724

DR   Cosmic; 1043237

DR   Cosmic; 1123332

DR   Cosmic; 1612900

DR   Cosmic-CLP; 753614

DR   GDSC; 753614

DR   GEO; GSM887694

DR   GEO; GSM888787

DR   GEO; GSM1670532

DR   PRIDE; PXD002486

DR   RCB; RCB1951

DR   TKG; TKG 0266

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 37 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 9

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 9

ST   vWA: 15,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE-2

AC   CVCL_4455

SY   TE2

DR   BTO; BTO:0002866

DR   BioSample; SAMN03151965

DR   CGH-DB; 306-1

DR   CGH-DB; 9255-4

DR   ChEMBL-Cells; CHEMBL3307467

DR   ChEMBL-Targets; CHEMBL615011

DR   Cosmic; 730307

DR   Cosmic; 735782

DR   Cosmic; 801323

DR   Cosmic; 923174

DR   Cosmic; 926098

DR   Cosmic; 947595

DR   Cosmic; 983714

DR   Cosmic; 1123319

DR   Cosmic; 1612897

DR   GEO; GSM301572

DR   TKG; TKG 0253

RX   PubMed=520749;

RX   PubMed=1778766;

RX   PubMed=2990217;

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).

CC   Doubling time: 72 hours (PubMed=520749).

CC   Discontinued: TKG; TKG 0253; probable.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9971 ! TE-3

OI   CVCL_9972 ! TE-7

OI   CVCL_1762 ! TE-12

OI   CVCL_4463 ! TE-13

SX   Male

CA   Cancer cell line

//

ID   TE-3

AC   CVCL_9971

SY   TE3

DR   BioSample; SAMN03151966

DR   CGH-DB; 9256-4

DR   Cosmic; 730318

DR   Cosmic; 735783

DR   Cosmic; 801324

DR   Cosmic; 923175

DR   Cosmic; 926099

DR   Cosmic; 932977

DR   Cosmic; 947596

DR   Cosmic; 983715

DR   Cosmic; 1043227

DR   Cosmic; 1123320

DR   GEO; GSM301573

DR   GEO; GSM1374959

DR   TKG; TKG 0254

RX   PubMed=1778766;

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=17804709;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).

CC   Omics: Transcriptome analysis.

CC   Discontinued: TKG; TKG 0254; probable.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4455 ! TE-2

OI   CVCL_9972 ! TE-7

OI   CVCL_1762 ! TE-12

OI   CVCL_4463 ! TE-13

SX   Male

CA   Cancer cell line

//

ID   TE-4

AC   CVCL_3337

SY   TE4

DR   CLO; CLO_0051377

DR   BioSample; SAMN03472060

DR   CCLE; TE4_OESOPHAGUS

DR   CGH-DB; 307-1

DR   CGH-DB; 9257-4

DR   Cosmic; 735828

DR   Cosmic; 801325

DR   Cosmic; 926100

DR   Cosmic; 983716

DR   Cosmic; 1123321

DR   Cosmic; 1571757

DR   Cosmic; 2546865

DR   Cosmic-CLP; 1503371

DR   GDSC; 1503371

DR   GEO; GSM887697

DR   GEO; GSM888790

DR   GEO; GSM1670533

DR   RCB; RCB2097

DR   TKG; TKG 0255

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17325662;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,10

ST   D5S818: 10

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE-5

AC   CVCL_1764

SY   TE5

DR   CLO; CLO_0051375

DR   BioSample; SAMN03472039

DR   CCLE; TE5_OESOPHAGUS

DR   CGH-DB; 308-1

DR   CGH-DB; 9258-4

DR   ChEMBL-Cells; CHEMBL3308179

DR   ChEMBL-Targets; CHEMBL2366245

DR   Cosmic; 735784

DR   Cosmic; 801326

DR   Cosmic; 923176

DR   Cosmic; 926101

DR   Cosmic; 947597

DR   Cosmic; 983717

DR   Cosmic; 1043228

DR   Cosmic; 1123322

DR   Cosmic-CLP; 735784

DR   GDSC; 735784

DR   GEO; GSM887698

DR   GEO; GSM888791

DR   GEO; GSM1670535

DR   RCB; RCB1949

DR   TKG; TKG 0256

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28224081;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 10

ST   D16S539: 9,10

ST   D5S818: 9

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TE-6

AC   CVCL_1765

SY   TE6

DR   BTO; BTO:0002867

DR   CLO; CLO_0051376

DR   BioSample; SAMN03472040

DR   CCLE; TE6_OESOPHAGUS

DR   CGH-DB; 309-1

DR   CGH-DB; 9259-4

DR   ChEMBL-Cells; CHEMBL3308180

DR   ChEMBL-Targets; CHEMBL2366144

DR   Cosmic; 735785

DR   Cosmic; 801327

DR   Cosmic; 926102

DR   Cosmic; 946355

DR   Cosmic; 983718

DR   Cosmic; 1123323

DR   Cosmic; 1571758

DR   Cosmic-CLP; 946355

DR   GDSC; 946355

DR   GEO; GSM887700

DR   GEO; GSM888793

DR   GEO; GSM1670536

DR   RCB; RCB1950

DR   TKG; TKG 0257

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 9,10

ST   D5S818: 10,13

ST   D7S820: 12

ST   TH01: 6,7

ST   TPOX: 12

ST   vWA: 17,19

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-6/Hypo

AC   CVCL_8325

RX   PubMed=21965748;

CC   Characteristics: Hypoxia-resistant.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1765 ! TE-6

SX   Male

CA   Cancer cell line

//

ID   TE-7

AC   CVCL_9972

SY   TE7

DR   BioSample; SAMN03151967

DR   CGH-DB; 310-1

DR   Cosmic; 735786

DR   Cosmic; 926103

DR   Cosmic; 983719

DR   Cosmic; 1043229

DR   Cosmic; 1123324

DR   Cosmic; 1571759

DR   GEO; GSM482500

DR   GEO; GSM827183

DR   GEO; GSM1374960

DR   TKG; TKG 0258

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=16364037;

RX   PubMed=17804709;

RX   PubMed=20143388;

RX   PubMed=23795680;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).

CC   Omics: Transcriptome analysis.

CC   Discontinued: TKG; TKG 0258; probable.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4455 ! TE-2

OI   CVCL_9971 ! TE-3

OI   CVCL_1762 ! TE-12

OI   CVCL_4463 ! TE-13

SX   Male

CA   Cancer cell line

//

ID   TE-8

AC   CVCL_1766

SY   TE8

DR   BTO; BTO:0004600

DR   CLO; CLO_0051371

DR   BioSample; SAMN03472061

DR   CCLE; TE8_OESOPHAGUS

DR   CGH-DB; 311-1

DR   CGH-DB; 9260-4

DR   ChEMBL-Cells; CHEMBL3308525

DR   ChEMBL-Targets; CHEMBL2366182

DR   Cosmic; 730329

DR   Cosmic; 753623

DR   Cosmic; 735787

DR   Cosmic; 801328

DR   Cosmic; 923177

DR   Cosmic; 926104

DR   Cosmic; 983720

DR   Cosmic; 1043230

DR   Cosmic; 1123325

DR   Cosmic; 1612898

DR   Cosmic; 2546866

DR   Cosmic-CLP; 753623

DR   GDSC; 753623

DR   GEO; GSM887701

DR   GEO; GSM888794

DR   GEO; GSM1670537

DR   RCB; RCB2098

DR   TKG; TKG 0259

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17325662;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28224081;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 6,7

ST   TPOX: 9 (Cosmic-CLP)

ST   TPOX: 8,9 (RCB; TKG)

ST   vWA: 14,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TE-9

AC   CVCL_1767

SY   TE9; Te9

DR   CLO; CLO_0051379

DR   BioSample; SAMN03472053

DR   CCLE; TE9_OESOPHAGUS

DR   CGH-DB; 312-1

DR   CGH-DB; 9261-4

DR   ChEMBL-Cells; CHEMBL3308181

DR   ChEMBL-Targets; CHEMBL2366147

DR   Cosmic; 730340

DR   Cosmic; 735788

DR   Cosmic; 923178

DR   Cosmic; 926105

DR   Cosmic; 946353

DR   Cosmic; 983721

DR   Cosmic; 1043231

DR   Cosmic; 1123326

DR   Cosmic-CLP; 946353

DR   GDSC; 946353

DR   GEO; GSM887702

DR   GEO; GSM888795

DR   GEO; GSM1670538

DR   PRIDE; PXD002486

DR   RCB; RCB1988

DR   TKG; TKG 0260

RX   PubMed=8509434;

RX   PubMed=9290701;

RX   PubMed=15172977;

RX   PubMed=17804709;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 25 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 9,13

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 100及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。